US pharmaceutical company Eli Lilly & Co expects its new weight-loss pill, orforglipron, to be approved as early as 2026, according to CEO Dave Ricks. The company anticipates receiving data on the experimental medication before mid-2025, which could lead to clearance in the following year.
Source: https://www.bloomberg.com/news/articles/2025-01-13/lilly-sees-new-weight-loss-pill-approval-in-early-2026-ceo-says